Loomis, Sayles & Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$644M |
| 2 |
Meta Platforms (Facebook)
META
|
+$345M |
| 3 |
Nike
NKE
|
+$74.6M |
| 4 |
Zions Bancorporation
ZION
|
+$71.9M |
| 5 |
Vanguard Growth ETF
VUG
|
+$48.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$435M |
| 2 |
Novartis
NVS
|
+$336M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$280M |
| 4 |
Monster Beverage
MNST
|
+$214M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.05% |
| 4 | Communication Services | 13.59% |
| 5 | Financials | 12.59% |
Similar funds
Loomis, Sayles & Company's Q4 2022 Portfolio in Review
As of Q4 2022, Loomis, Sayles & Company held 1,025 positions worth $49.9B, up 1.2% from $49.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Loomis, Sayles & Company withdrew a net $2.78B in Q4 2022, closing 173 positions and reducing 366 holdings. Its most notable exit was TechTarget, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in Zions Bancorporation worth $70.7M.
- Loomis, Sayles & Company's largest Q4 2022 buy was Zions Bancorporation: 1,438,015 shares worth $70.7M.
- Loomis, Sayles & Company added most to Tesla in Q4 2022, an estimated $644M increase.
- Loomis, Sayles & Company's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $435M.
- Loomis, Sayles & Company fully exited TechTarget in Q4 2022, selling an estimated $41M.
- Loomis, Sayles & Company's ten largest holdings make up 36% of its $49.9B portfolio in Q4 2022.
- Loomis, Sayles & Company opened 73 new positions and closed 173 in Q4 2022.
- Loomis, Sayles & Company's portfolio value rose 1.2% quarter-over-quarter to $49.9B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2022, filed 10 Feb 2023.